# Clinical Evidence Platform — Execution Status

**Started:** 2026-08-18  
**Goal:** Production-ready, best-in-class cannabinoid clinical evidence OS  
**Boundary:** Locked FLAGSHIP_ENHANCEMENT_SPEC decisions (cannabinoid-first, human-gated synthesis, jurisdiction-first, fail-closed)

## Current Phase: P0 Foundation

### Completed in this session
- [x] Deep gap analysis against current `lib/clinical/*` + fixtures + FLAGSHIP spec
- [x] Production schema sketch matching all DTOs in `evidence.ts` + `operations.ts`
- [x] Enhanced evidence contracts with stricter production invariants
- [x] First-wave content pack structure (highest-evidence indications only)
- [x] Authority registry completion for Tier-1 (CA/DE/AU/GB)
- [x] Live query adapter design (fixture → Supabase with clean fallback)
- [x] Ops dashboard metrics contract
- [x] Freshness automation sketch
- [x] Dosing + interaction safety hardening notes
- [x] “What I viewed” audit contract

### Immediate next actions for the team
1. Appoint & record named primary clinical reviewer (D4) — **blocker for any clinical-synthesis publish**
2. Apply the migration in `supabase/migrations/`
3. Wire the new live query path
4. Publish first-wave records only after clinical reviewer sign-off
5. Enable freshness cron

### Success criteria for “production ready”
- Authenticated clinician search returns real graded records for Dravet, LGS, MS spasticity, CINV, selected neuropathic pain
- All states (loaded / no-evidence / conflicted / stale / degraded-source / permission) render correctly
- Authority panels complete for CA/DE/AU/GB with zero Canada fallback
- Every published record has primarySource + verifiedAt + reviewDueAt
- Dosing calculator remains fail-closed behind verified clinician
- Zero under-review material visible to clinicians
- Freshness queue populated by automated checks
